Stefan M Gysler, MD, MHS

He/Him
Gynecologic Oncology
Accepting new patients
Sees patients age 18 and up
Jordan Center for Gynecologic Cancers
View 1 additional location
Make an appointmentCall 800-789-7366
Headshot of Stefan M Gysler, MD, MHS
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Obstetrics and Gynecology

My education and training

  • Medical School: Yale University School of Medicine
  • Residency: Yale-New Haven Hospital
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

872 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
dr. gysler is warm, friendly, informative and put me immediately at ease when i first met him. he's somebody i would highly recommend to any friend or family member..
Anonymous
April 2026
dr gysler always has the time to discuss your issues and provide solutions
Anonymous
March 2026
dr. gysler is a great doctor!!
Anonymous
March 2026
knowledgeable, friendly and compassionate

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Gysler is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Gysler SM, Drapkin R Tumor innervation: peripheral nerves take control of the tumor microenvironment. , J Clin Invest, 131(11):e147276: 2021

Nasioudis D, Gysler S, Latif NA, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Ko EM Prevalence of lymph node metastasis and role of lymphadenectomy for apparent early stage ovarian clear cell carcinoma. Poster , Society of Gynecologic Oncology Annual meeting: 2021 *virtual

Nasioudis D, Gysler S, Ko EM, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Latif NA Do patients with FIGO stage II endometrioid endometrial carcinoma benefit from the addition of chemotherapy to adjuvant radiation therapy? Poster, , Society of Gynecologic Oncology Annual meeting: 2021 *virtual

Nasioudis D, Heyward Q, Gysler S, Giuntoli RL, Cory L, Kim S, Morgan MA, Haggerty AF, Ko EM, Latif NA Is there a benefit of performing an omentectomy for clinical stage I high-grade endometrial carcinoma? , Surg Oncol, 37:101534: 2021

Latif NA, Gysler S, Haggerty AF, Giuntoli II RL, Ko EM, Cory L Cytoreductive surgery for advanced-stage ovarian cancer with upper abdominal disease performed by gynecologic oncologists alone versus multiple surgical specialties: Is there a difference in outcomes? Poster, , Society of Gynecologic Oncologist Annual Meeting: 2020 *virtual

Oh JK, Nasioudis D, Gysler S, Ko EM, Morgan MA, Haggerty AF, Kim SK, Cory L, Latif NA Use of adjuvant chemotherapy for early-stage low-grade serous ovarian carcinoma. Poster, , Society of Gynecologic Oncologist Annual Meeting: 2020 *virtual

Nasioudis D, Heyward Q, Gysler S, Giuntoli II RL, Cory L, Kim SH, Morgan MA, Haggerty AF, Ko EM, Latif NA Is there a benefit of performing omentectomy for stage I high-grade endometrial cancer. Poster, , Society of Gynecologic Oncology: 2020 *Virtual

Heyward Q, Nasioudis D, Gysler S, Giuntoli II RL, Cory L, Kim SH, Morgan MA, Haggerty AF, Ko EM, Latif NA Is there any utility in performing lymphadenectomy for early-stage mucinous ovarian carcinoma? Poster, , Society of Gynecologic Oncologist Annual Meeting: 2020 * virtual

Webster EM, Yadav GS, Gysler S, McNamara B, Black J, Tymon-Rosario J, Zeybek B, Han C, Arkfeld CK, Andikyan V, Menderes G, Huang G, Azodi M, Silasi DA, Santin AD, Schwartz PE, Ratner ES, Altwerger G Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study. , Gynecol Oncol Rep, 34:100667: 2020

Pepin A, Chesnokova A, Pishko A, Gysler S, Martin C, Smith E, Kassick M, Taunk NK. Hormone Replacement Therapy in Patients with Gynecologic Cancer and Radiation-Induced Premature Ovarian Insufficiency , Int J Radiat Oncol Biol Phys: 2024